SEEQC UK Announces Three New Project Awards by Innovate UK’s Industrial Strategy Challenge Fund (...

The first is a  £6.85 million ($9.25M USD) grant from Innovate UK to build a commercially scalable application-specific quantum computer designed to tackle prohibitively high costs within pharmaceutical drug development. SEEQC will lead this project and will include other members of the consortium including Riverlane, Oxford Instruments, the University of Oxford, Medicines Discovery Catapult, and members from the Science and Technology Facilities Council, including the UK’s National Quantum Computing Centre as well as end user Merck who is both a partner on this project as well as a strategic investor in SEEQC. The goal of this project will be to use SEEQC’s quantum computer to perform a quantum simulation designed to support core elements of this use case on its full-stack platform and demonstrate a clear route to commercial scalability towards simulations of drugs for photodynamic cancer therapies. Merck will benchmark the performance of this application-specific machine and determine its commercial viability to support its global R&D efforts.

The second project is a £6.8 million ($9.1M USD) initiative led by Riverlane, to develop advanced quantum calibration methods that utilize machine learning and support the integration of SEEQC’s unique superconducting classical logic platform with cryoCMOS components to support deep memory.

And the third project is a £6.5 million ($8.77M USD) initiative led by sureCore, will also support the integration of SEEQC’s unique superconducting classical logic platform with cryoCMOS components, combining the optimal features of each component in support of the company’s platform development.

Additional informaiton about these awards can be found in a news release provided by SEEQC that can be found here.

November 5, 2021